S. T. Kim
University of Queensland
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. T. Kim.
Genes and Immunity | 2003
Ian A. Yang; S. L. Seeney; J. M. Wolter; E M Anders; Joseph G. McCormack; A. M. Tunnicliffe; G. C. Rabnott; Janet G. Shaw; Annette G. Dent; S. T. Kim; P. V. Zimmerman; Kwun M. Fong
Infection frequently causes exacerbations of chronic obstructive pulmonary disease (COPD). Mannose-binding lectin (MBL) is a pattern-recognition receptor that assists in clearing microorganisms. Polymorphisms in the MBL2 gene reduce serum MBL levels and are associated with risk of infection. We studied whether the MBL2 codon 54 B allele affected serum MBL levels, admissions for infective exacerbation in COPD and disease susceptibility. Polymorphism frequency was determined by PCR-RFLP in 200 COPD patients and 104 smokers with normal lung function. Serum MBL was measured as mannan-binding activity in a subgroup of 82 stable COPD patients. Frequency of COPD admissions for infective exacerbation was ascertained for a 2-year period. The MBL2 codon 54 B allele reduced serum MBL in COPD patients. In keeping, patients carrying the low MBL-producing B allele had increased risk of admission for infective exacerbation (OR 4.9, Pcorrected=0.011). No association of MBL2 genotype with susceptibility to COPD was detected. In COPD, serum MBL is regulated by polymorphism at codon 54 in its encoding gene. Low MBL-producing genotypes were associated with more frequent admissions to hospital with respiratory infection, suggesting that the MBL2 gene is disease-modifying in COPD. MBL2 genotype should be explored prospectively as a prognostic marker for infection risk in COPD.
Current Opinion in Allergy and Clinical Immunology | 2007
Ian A. Yang; Santiyagu M. Savarimuthu; S. T. Kim; John W. Holloway; Scott C. Bell; Kwun M. Fong
Purpose of review Asthma is likely to result from the effects of environmental stimuli in genetically susceptible individuals. This review summarizes recent studies of gene–environmental interaction in the pathogenesis of asthma, focusing on study designs. Recent findings Studies using genetic epidemiology, in-vitro and ex-vivo models and in-vivo model organisms demonstrate that gene–environmental interaction in involved in the development of asthma. Genetic association studies show a reduced risk of asthma and atopy with early life exposure to farming environments and house dust endotoxin, and increased risk with environmental tobacco smoke. These associations are modified by CD14 genotype. In people with a specific genotype, high environmental exposure may have the opposite effect of low exposure, possibly explaining some of the inconsistencies in previous studies. In-vitro and ex-vivo cell culture experiments show gene–environmental interactions with Toll-like receptor agonists, viruses and tobacco smoke. Interactions between innate immunity genes and exposure to endotoxin and air pollution have been observed in in-vivo mouse models. Summary The expanding evidence for gene–environmental interaction in asthma indicates the importance of measuring environmental factors in genetic studies of asthma. Understanding gene–environmental interaction would facilitate risk prognostication, improve preventive strategies and develop targeted interventions in people with asthma.
Respirology | 2003
S. T. Kim; Omar M. Kaisar; Belinda E. Clarke; Russell A. Vandenburg; David H. Allen; Scott C. Bell; Kwun M. Fong
Abstract: Three confirmed cases of acute iron tablet‐induced necrosis due to a fulminant chemical burn injury to the tracheobronchial tree as a result of accidental inhalation and/or aspiration of iron tablets are described. Although histological confirmation has been relied upon for diagnosis, the distinctive bronchoscopic features may allow prompt recognition and treatment by bronchoscopists to prevent this potentially fatal condition.
Evidence-based Respiratory Medicine | 2007
Ian A. Yang; S. T. Kim; Scott C. Bell
Array | 2005
S. T. Kim; Ian A. Yang; Scott C. Bell
2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand | 2005
S. T. Kim; Linda Passmore; Annette G. Dent; R. Slaughter; Ian A. Yang; Kwun M. Fong; P. V. Zimmerman; Scott C. Bell
2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand | 2005
Ian A. Yang; S. T. Kim; Scott C. Bell
18th Annual North American Cystic Fibrosis Conference | 2004
F. D. Kermeen; S. T. Kim; Timothy J. Kidd; C. Coulter; Ristan M. Greer; Scott C. Bell
5th Australian & New Zealand Cystic Fibrosis Conference 2003 | 2003
P. J. Masel; J. Bunting; C. Franks; S. T. Kim; Timothy J. Kidd; Scott C. Bell